Opioid crisis in America

Opioid crisis in America: Your assignment should be based on the below template/outline. Further, you should include these 4 bolded-headings in your paper.

Opioid crisis in America

Your assignment should be based on the below template/outline. Further, you should include these 4 bolded-headings in your paper.

Introduction/overview of topic-Opioid crisis: what is it, who it affects, how many people does it affect, who is at highest risk, when did it start.

Body – Opioid crisis:

Firstly, who is at fault

Secondly, what is currently being done to protect Americans

Thirdly, what are financial, social, and economic impacts.

Conclusion – Summary of takeaways from article and offer suggestions/opinions for areas of improvement.

Firstly, what did you learn that you didn’t already know-

Additionally, give details about what you learn and what your takeaway is from the article.

More details;

The accepted wisdom about the US overdose crisis singles out prescribing as the causative vector. Drug supply is a key factor. We posit that the crisis is fundamentally fuel by economic and social upheaval. Its etiology closely linked to the role of opioids as a refuge from physical and psychological trauma. Concentrated disadvantage, isolation, and hopelessness.

Overreliance on opioid medications is emblematic of a health care system that incentivizes quick, simplistic answers to complex physical and mental health needs. In an analogous way, simplistic measures to cut access to opioids offer illusory solutions to this multidimensional societal challenge.

We trace the crisis’ trajectory through the intertwined use of opioid analgesics, heroin, and fentanyl analogs, and we urge engaging the structural determinants lens to address this formidable public health emergency. A broad focus on suffering should guide both patient- and community-level interventions.

The accepted wisdom about the US opioid crisis singles out opioid analgesics as causative agents of harm. Physicians as unwitting conduits and pharmaceutical companies as selfish promoters.